Effects of Upper and Lower Limb Exercises on Muscle Strength, Aerobic Capacity and Respiratory Functions in Children With Cystic Fibrosis
Led by Riphah International University · Updated on 2026-04-02
22
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
This research focuses on children aged 6 to 18 years diagnosed with cystic fibrosis, a genetic disorder that affects lung function and muscle strength. The study aims to compare the effects of upper and lower limb exercises on muscle strength, aerobic capacity, and respiratory functions. It highlights how resistance training targeting specific limbs may improve respiratory muscle endurance, mobility, oxygen consumption, and overall physical performance in this population.
Participants will be randomly assigned to one of two exercise programs. One group will perform upper limb resistance training using an arm cycle ergometer with sessions 2-3 times per week, including warm-up, training at 50-85% peak resistance, and cool-down. The other group will engage in lower limb resistance training using a leg cycle ergometer under a similar schedule and intensity. Each session includes 1-3 sets of 6-15 revolutions with rest periods.
Children will be assessed at baseline, 4 weeks, and 8 weeks for lung function via spirometry, sputum production recorded in diaries, aerobic capacity measured by the Incremental Shuttle Walk Test, upper limb muscle strength using handheld dynamometry, and lower limb strength with the Sit-to-Stand Test. The study will monitor exercise adherence and measure changes in respiratory and muscle function over the trial period, which lasts ten months after approval.
CONDITIONS
Brief Title
Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis
Who Can Participate
Age: 6Years - 18Years
All Genders
Eligibility Criteria
You may qualify if you...
Children aged 6-18 years
Diagnosed with cystic fibrosis
Clinically stable
Able to perform exercise
Parental or guardian consent provided
You will not qualify if you...
Other severe pulmonary diseases
Cardiovascular or orthopedic limitations
Surgery or hospitalization within last 1 month
Inability to follow instructions
Oxygen-dependent or ventilator-dependent patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 8 weeks
Participants undergo either upper limb or lower limb resistance training using a cycle ergometer designed to improve muscle strength and respiratory function.
2 to 3 exercise sessions per week plus 3 assessment visits at baseline, Week 4, and Week 8
The effects of aerobic exercises compared to conventional chest physiotherapy on pulmonary function, functional capacity, sputum culture, and quality of life in children and adolescents with cystic fibrosis: a study protocol for randomized controlled trial study.
Strength-Oriented Virtual Exercise Training Intervention in Children and Adolescents with Cystic Fibrosis Under CFTR Modulators (the FIQMODE Study): Study Protocol for a Randomized Controlled Trial.
Lisset Pantoja-Arévalo, Thomas Yvert, Tamara Iturriaga...